Taro-zoledronic Acid: The Affected Lots May Contain Particulate Matter

Taro-Zoledronic Acid Recall Summary Certain lots of Taro-Zoledronic Acid are being recalled in Canada because they may contain particulate matter (small particles) in the product. Zoledronic acid is a medication used to treat bone-related conditions. This is classified as a Class I recall, which is the most serious type, affecting products distributed across Canada.

Product

Taro-Zoledronic Acid

Reason

Product quality

Classification

Class I

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2022-08-10

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/94037201-7ebd-4e3e-9ac6-9d96642d9c33